Clinical trial
Signaling Pathway Activation in the Quadriceps of Patients With COPD After an Acute Bout of Resistance
NCT01561625 is registered in ClinicalTrials.gov with Laval University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Signaling Pathway Activation in the Quadriceps of Patients With COPD After an Acute Bout of Resistance
- Lead sponsor
- Laval University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2009
- Completion date
- April 30, 2013
- Enrollment
- 21 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic obstructive pulmonary disease